Publication | Closed Access

Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-Alzheimer’s agents through pharmacophore-based virtual screening, molecular docking and experimental validation

Molecular DockingMedicinal ChemistryNeurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineNatural SciencesRational Drug DesignNovel Fatty AcidDrug DevelopmentPharmacologyDrug DiscoveryPharmacophore-based Virtual Screening